Back to trial detailsIntake questionnaire
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Applying to Mary Crowley Cancer Research · Dallas, Texas
Answer a few short questions to share with the research team.
0 of 3 answered